Filing Details

Accession Number:
0001203311-23-000096
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-30 19:07:36
Reporting Period:
2023-08-28
Accepted Time:
2023-08-30 19:07:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1060736 Seagen Inc. SGEN Biological Products, (No Disgnostic Substances) (2836) 911874389
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1361966 B Vaughn Himes 21823 30Th Drive Se
Bothell WA 98021
Chief Technical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-28 937 $0.00 53,605 No 4 A Direct
Common Stock Disposition 2023-08-29 371 $206.00 53,234 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 119,471 Indirect by Trust
Footnotes
  1. The performance criteria for these restricted stock units were met. These restricted stock units became fully vested on 8/28/2023.
  2. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
  3. The sales reported in this Form 4 were effected pursuant to a written plan adopted on 11/3/2020 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).